207 related articles for article (PubMed ID: 35163412)
21. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
22. Role of CD1d in coxsackievirus B3-induced myocarditis.
Huber S; Sartini D; Exley M
J Immunol; 2003 Mar; 170(6):3147-53. PubMed ID: 12626572
[TBL] [Abstract][Full Text] [Related]
23. In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.
Althof N; Harkins S; Kemball CC; Flynn CT; Alirezaei M; Whitton JL
J Virol; 2014 May; 88(9):5087-99. PubMed ID: 24574394
[TBL] [Abstract][Full Text] [Related]
24. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
Liu H; Li M; Song Y; Xu W
Front Immunol; 2018; 9():2479. PubMed ID: 30410495
[TBL] [Abstract][Full Text] [Related]
25. Role of neutrophils in CVB3 infection and viral myocarditis.
Rivadeneyra L; Charó N; Kviatcovsky D; de la Barrera S; Gómez RM; Schattner M
J Mol Cell Cardiol; 2018 Dec; 125():149-161. PubMed ID: 30393107
[TBL] [Abstract][Full Text] [Related]
26. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
27. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
28. Vγ1
Wan F; Yan K; Xu D; Qian Q; Liu H; Li M; Xu W
Mol Immunol; 2017 Jan; 81():16-25. PubMed ID: 27886550
[TBL] [Abstract][Full Text] [Related]
29. Coxsackievirus B3-induced chronic myocarditis in mouse: use of whole blood culture to study the activation of TNF alpha-producing cells.
Hober D; Andreoletti L; Shen L; Copin MC; Desmidt A; Wattré P
Microbiol Immunol; 1996; 40(11):837-45. PubMed ID: 8985939
[TBL] [Abstract][Full Text] [Related]
30. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis.
Wang Y; Gao B; Xiong S
Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1438-47. PubMed ID: 25260607
[TBL] [Abstract][Full Text] [Related]
31. The adapter protein c-Cbl-associated protein (CAP) protects from acute CVB3-mediated myocarditis through stabilization of type I interferon production and reduced cytotoxicity.
Valaperti A; Nishii M; Liu Y; Yang H; Naito K; Liu PP; Eriksson U
Basic Res Cardiol; 2014 May; 109(3):411. PubMed ID: 24763933
[TBL] [Abstract][Full Text] [Related]
32. Coxsackievirus B3 induces viral myocarditis by upregulating toll-like receptor 4 expression.
Zhao Z; Cai TZ; Lu Y; Liu WJ; Cheng ML; Ji YQ
Biochemistry (Mosc); 2015 Apr; 80(4):455-62. PubMed ID: 25869363
[TBL] [Abstract][Full Text] [Related]
33. Unc93b1 -Dependent Endosomal Toll-Like Receptor Signaling Regulates Inflammation and Mortality during Coxsackievirus B3 Infection.
Lafferty EI; Wiltshire SA; Angers I; Vidal SM; Qureshi ST
J Innate Immun; 2015; 7(3):315-30. PubMed ID: 25675947
[TBL] [Abstract][Full Text] [Related]
34. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of IL-2 inducible T-cell kinase alleviates T-cell activation and murine myocardial inflammation associated with CVB3 infection.
He F; Yao H; Xiao Z; Han J; Zou J; Liu Z
Mol Immunol; 2014 May; 59(1):30-8. PubMed ID: 24462896
[TBL] [Abstract][Full Text] [Related]
36. [Effect of IL-17A on levels of antiheart autoantibodies in mice with viral myocarditis].
Lai W; Wu W; Pan X; Kong Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):601-3, 607. PubMed ID: 24909282
[TBL] [Abstract][Full Text] [Related]
37. Blockade of interleukin-17A protects against coxsackievirus B3-induced myocarditis by increasing COX-2/PGE2 production in the heart.
Xie Y; Chen R; Zhang X; Yu Y; Yang Y; Zou Y; Ge J; Chen H; Garzino-Demo A
FEMS Immunol Med Microbiol; 2012 Apr; 64(3):343-51. PubMed ID: 22141571
[TBL] [Abstract][Full Text] [Related]
38. Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis.
Jäkel S; Kuckelkorn U; Szalay G; Plötz M; Textoris-Taube K; Opitz E; Klingel K; Stevanovic S; Kandolf R; Kotsch K; Stangl K; Kloetzel PM; Voigt A
Am J Pathol; 2009 Aug; 175(2):510-8. PubMed ID: 19590042
[TBL] [Abstract][Full Text] [Related]
39. Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis.
Kaese S; Larbig R; Rohrbeck M; Frommeyer G; Dechering D; Olligs J; Schönhofer-Merl S; Wessely R; Klingel K; Seebohm G; Eckardt L
PLoS One; 2017; 12(6):e0180029. PubMed ID: 28644868
[TBL] [Abstract][Full Text] [Related]
40. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication.
Fairweather D; Yusung S; Frisancho S; Barrett M; Gatewood S; Steele R; Rose NR
J Immunol; 2003 May; 170(9):4731-7. PubMed ID: 12707353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
